E-phys’ expertise is based on many years of experience of the founder and collaborators within drug discovery research in CROs and large pharmaceutical companies.
E-phys’ activity started in summer 2012, with the installation of its own dedicated in vivo electrophysiology platform within the medical and pharmaceutical school in the Université d’Auvergne, Clermont-Ferrand, France.
The use of animals is at the very heart of our work. Accordingly, E-Phys is committed to maximising the well-being of the animals we use, adhering to all legal requirements of in vivo preclinical research and respecting the core philosophy of the 3Rs. Specifically:
Selecting the next drug candidate or validating a new target share a common requirement: data you can rely on.
The fate of a project eventually depends on the quality of the data included in the preclinical package.
E-Phys has not received any reviews.
E-Phys has not received any endorsements.